Comparison of impact of mortality risk on the survival benefit of primary percutaneous coronary intervention versus facilitated percutaneous coronary intervention

American Journal of Cardiology

Volumn 107, Issue 2, 2011, Pages 220-224

  Tarantini, Giuseppe ^a   Facchin, Michela ^a   Frigo, Anna Chiara ^b   Welsh, Robert ^c  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b Department of Environmental Medicine and Public Health ^*  (Italy)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FACILITATED PERCUTANEOUS CORONARY INTERVENTION; HUMAN; INTERMETHOD COMPARISON; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIMARY PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; HUMANS; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 78650862888     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.09.005     Document Type: Review

References (29)

1. H.C. Herrmann, J. Lu, B.R. Brodie, P.W. Armstrong, G. Montalescot, A. Betriu, F.J. Neuman, M.B. Effron, E.S. Barnathan, E.J. Topol, S.J. Ellis FINESSE Investigators Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals JACC Cardiovasc Interv 2 2009 917 924
2. A.M. Ross, K. Huber, U. Zeymer, P.W. Armstrong, C.B. Granger, P. Goldstein, K. Bogaerts, and F. Van de Werf The impact of place of enrollment and delay to reperfusion on 90-days post-infarction mortality in the ASSENT-4 PCI trial: assessment of the safety and efficacy of a new treatment strategy with percutaneous coronary intervention JACC Cardiovasc Interv 2 2009 925 930
3. ASSENT 4 Investigators Primary vs. tenecteplase facilitated percutaneous coronary intervention in patients with ST-elevation acute myocardial infarction: the ASSENT-4 PCI randomized trial Lancet 367 2006 569 578
4. S.G. Ellis, M. Tendera, M.A. de Belder, A. van Boven, P. Widimsky, L. Janssens, H.R. Andersen, A. Betriu, S. Savonitto, J. Adamus, J.Z. Peruga, M. Kosmider, O. Katz, T. Neunteufl, J. Jorgova, M. Dorobantu, L. Grinfeld, P. Armstrong, B.R. Brodie, H.C. Herrmann, G. Montalescot, F.J. Neumann, M.B. Effron, E.S. Barnathan, E.J. Topol FINESSE Investigators Facilitated PCI in patients with ST-elevation myocardial infarction N Engl J Med 358 2008 2205 2217
5. W.W. O'Neill, Weintraub, C.L. Grines, T.B. Meany, R.B. Brodie, H.Z. Friedman, R.G. Ramos, V. Gangadharan, R.N. Levin, and N. Choksi A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction RN Circulation 86 1992 1710 1717
6. F. Vermeer, A.J.M.O. Ophuis, E.J. Berg, L.G. Brunninkhuis, C.J. Werter, A.G. Boehmer, A.H. Lousberg, W.R. Dassen, and F.W. Br Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study Heart 82 1999 426 431
7. A.M. Ross, K.S. Coyne, J.S. Reiner, S.W. Greenhouse, C. Fink, A. Frey, E. Moreyra, M. Traboulsi, N. Racine, A.L. Riba, M.A. Thompson, S. Rohrbeck, and C.F. Lundergan A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial J Am Coll Cardiol 34 1999 1954 1962
8. F. Fernndez-Avils, J.J. Alonso, G. Pea, J. Blanco, J. Alonso-Briales, J. Lpez-Mesa, F. Fernndez-Vzquez, J. Moreu, R.A. Hernndez, A. Castro-Beiras, R. Gabriel, C.M. Gibson, P.L. Snchez GRACIA-2 (Groupo de Anlisis de Cardiopata Isqumica Aguda) Investigators Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial Eur Heart J 28 2007 949 960
9. P.W. Armstrong WEST Steering Committee A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-Elevation Myocardial Infarction Therapy) study Eur Heart J 27 2006 1530 1538
10. H.C. Herrmann, D.J. Moliterno, E.M. Ohman, A.L. Stebbins, C. Bode, A. Betriu, F. Forycki, J.S. Miklin, W.B. Bachinsky, A.M. Lincoff, R.M. Califf, and E.J. Topol Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 pilot) trial J Am Coll Cardiol 36 2000 1489 1496
11. A. Kastrati, J. Mehilli, K. Schlotterbeck, F. Dotzer, J. Dirschinger, C. Schmitt, S.G. Nekolla, M. Seyfarth, S. Martinoff, C. Markwardt, G. Clermont, H.W. Gerbig, J. Leiss, M. Schwaiger, A. Schmig Bavarian Reperfusion Alternatives Evaluation (BRAVE) Study Investigators Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial JAMA 291 2004 947 954
12. The Advance MI Investigators Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: results from the prematurely terminated Addressing the Value of Facilitated Angioplasty After Combination Therapy or Eptifibatide Monotherapy in Acute Myocardial Infarction (ADVANCE MI) trial Am Heart J 150 2005 116 122
13. A. Wong, K.H. Mak, C. Chan, T.H. Koh, K.W. Lau, T.T. Lim, S.T. Lim, P. Wong, L.L. Sim, Y.T. Lim, H.C. Tan, and Y.L. Lim Combined fibrinolysis using reduced-dose alteplase plus abciximab with immediate rescue angioplasty versus primary angioplasty with adjunct use of abciximab for the treatment of acute myocardial infarction: Asia-Pacific Acute Myocardial Infarction Trial (APAMIT) pilot study Catheter Cardiovasc Interv 62 2004 445 452
14. S. Peters, M. Truemmel, and B. Koehler Facilitated PCI by combination fibrinolysis or upstream tirofiban in acute ST-segment elevation myocardial infarction: results of the Alteplase and Tirofiban in Acute Myocardial Infarction (ATAMI) trial Int J Cardiol 130 2008 235 240
15. P. Widimsk, L. Groch, M. Zelzko, M. Aschermann, F. Bednr, and H. Suryapranata Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterisation laboratory: the PRAGUE study Eur Heart J 21 2000 823 831
16. D. Moher, D.J. Cook, S. Eastwood, I. Olkin, D. Rennie, and D.F. Stroup Improving the quality of reports of meta-analyses of randomized controlled trials: the QUORUM statement Lancet 354 1999 1896 1900
17. D.M. Kent, C.H. Schmid, J. Lau, and H.P. Selker Is primary angioplasty for some as good as primary angioplasty for all? Modelling across trials and individual patients J Gen Intern Med 17 2002 887 894
18. C.H. Schmid, J. Lau, M.W. McIntosh, and J.C. Cappelleri An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials Stat Med 17 1998 1923 1942
19. th ed. 1996 McGraw-Hill Boston, Massachusetts
20. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction a quantitative review of 23 randomized trials Lancet 361 2003 13 20
21. B.J. Gersh, G.W. Stone, H.D. White, and D.R. Holmes Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction Is the slope of the curve the shape of the future? JAMA 293 2005 979 986
22. J.G. Canto, R.J. Zalenski, J.P. Ornato, W.J. Rogers, Kiefe, D. Magid, M.G. Shlipak, P.D. Frederick, C.G. Lambrew, K.A. Littrell, H.V. Barron National Registry of Myocardial Infarction 2 Investigators Use of emergency medical services in acute myocardial infarction and subsequent quality of care: observations from the National Registry of Myocardial Infarction 2 Circulation 106 2002 3018 3023
23. G.W. Stone, D. Cox, E. Garcia, B.R. Brodie, M.C. Morice, J. Griffin, L. Mattos, A.J. Lansky, W.W. O'Neill, and C.L. Grines Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the Primary Angioplasty in Myocardial Infarction Trials Circulation 104 2001 636 641
24. G.W. Stone, M.A. Peterson, A.J. Lansky, J. Dangas, R. Mehran, and M.B. Leon Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction J Am Coll Cardiol 39 2002 591 597
25. C. Basso, and G. Thiene The pathophysiology of myocardial reperfusion: a pathologist's perspective Heart 92 2006 1559 1562
26. C.H. Schmid, J. Lau, M.W. McIntosh, and J.C. Cappelleri An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials Stat Med 17 1998 1923 1942
27. P.W. Armstrong, Y. Fu, C.M. Westerhout, M.P. Hudson, K.W. Mahaffey, H.D. White, T.G. Todaro, P.X. Adams, P.E. Aylward, and C.B. Granger Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention J Am Coll Cardiol 53 2009 1503 1509
28. P.W. Armstrong, C.M. Westerhout, and R.C. Welsh Duration of symptoms is the key modulator of the choice of reperfusion for ST-elevation myocardial infarction Circulation 119 2009 1293 1303
29. P.W. Armstrong, A. Gershlick, P. Goldstein, R. Wilcox, T. Danays, E. Bluhmki, F. Van de Werf STREAM Steering Committee The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study Am Heart J 160 2010 30 35